Pain Relief from headache and musculoskeletal pain
Prescription/Non-Prescription
Prescription
Also Gives
PCD Pharma Franchise
Marketed by
Accubic Labs pvt ltd
Country of Origin
Made in India
Availability
In Stock
ACLOMOL-SP TABLET - Aceclofenac 100mg, Paracetamol 325mg, Serratiopeptidase 15mg At ACCUBIC LABS PVT. LTD we specialize in providing PCD Pharma Franchise opportunities on a monopoly basis. Our extensive portfolio includes over 300 high-quality pharmaceutical products across various therapeutic segments. In addition to our franchise offerings, we also provide third-party manufacturing services to meet diverse market needs.
Our manufacturing unit, operating under the name HEALTHWISE PHARMA is proudly WHO-GMP certified, ensuring adherence to international quality standards. We are particularly renowned for our expertise in the production of SOFTGEL CAPSULES, a specialized area where we excel in delivering exceptional quality and innovation.
Find products similar to Aceclofenac Paracetamol Serratiopeptidase Tablet
Interested in this product?Get Latest Price from the seller
About the Company
GST Registration Date
29-01-2022
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
26 To 50 People
Annual Turnover
40 L - 1.5 Cr
IndiaMART Member Since
Nov 2023
GST
02AAWCA3690B1ZS
Established in the year of 2021. We “Accubic Labs Private Limited” are a leading Manufacturer , Supplier , Service Provider, Wholesaler, Distributor of a wide range of Pharmaceutical Tablets, Pharmaceutical Capsules, Allopathic Pcd Pharma Franchise etc.
We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.
For our accomplishment story, we are grateful to Our CEO Daljinder Saini, whose continual backing and direction have been useful to us for attaining exponential development in the current market
